Sign in

Private company

SomaLogic, Inc.

American commercial physical and biological research services company1

In its 2023 annual report the company says: “SomaLogic is a leading commercial-stage proteomics company. We currently run our platform within our own laboratory, receive samples from customers and perform proteomics analysis on their behalf.”56 It is headquartered in Boulder, Colorado.1

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Commercial Physical & Biological Research1
  • HeadquartersBoulder, Colorado1
  • Incorporated inDE2
  • Business addressC/O Somalogic, Inc., 2945 Wilderness Place, Boulder, Co 803012
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-180.0%Operating margin3
-111.8%Net margin3
19.7%Revenue growth, 20223
-19.4%Return on equity3
-$105.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development32¢$73.4M
  • Selling, general and admin68¢$156.6M
  • Income tax0¢$717.0K

Out of $97.7M in revenue.3 The company lost money this year.

Financial statements

Revenue43$97.7M in 2022+75% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $55.9M$55.9M20202021: $81.6M$81.6M2021+46%2022: $97.7M$97.7M2022+20%
Operating income43-$175.8M in 2022+412% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$34.4M-$34.4M20202021: -$73.3M-$73.3M2021+113%2022: -$175.8M-$175.8M2022+140%
Net income43-$109.2M in 2022+106% since 2020
-$150.0M-$100.0M-$50.0M02020: -$53.0M-$53.0M20202021: -$87.5M-$87.5M2021+65%2022: -$109.2M-$109.2M2022+25%
Fiscal year2019202020212022
Revenue$55.9M4$81.6M3$97.7M3
Research and development$30.7M4$43.5M3$73.4M3
Selling, general and admin$36.9M4$78.0M3$156.6M3
Operating expenses$154.9M3$273.4M3
Operating income-$34.4M4-$73.3M3-$175.8M3
Interest$18.3M4$1.3M3$03
Income before tax-$87.5M3-$109.9M3
Income tax$23.0K4$38.0K3-$717.0K3
Net income-$53.0M4-$87.5M3-$109.2M3
Earnings per share-$0.814-$0.643-$0.593
Earnings per share (diluted)-$0.814-$0.643-$0.593
Shares (weighted, basic)137.2M shares3184.0M shares3
Shares (weighted, diluted)137.2M shares3184.0M shares3

Compare SomaLogic, Inc. with another company

Corporate structure

SomaLogic, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of SomaLogic, Inc.

  • ARK Investment Management LLC Filed SCHEDULE 13G/A on SomaLogic, Inc., latest Jan 10, 2025 (2 filings since Jan 29, 2024)
  • BlackRock Filed SC 13G/A on SomaLogic, Inc., latest Jan 29, 2024 (2 filings since Feb 3, 2023)
  • CMLS Holdings II LLC Filed SC 13D/A on SomaLogic, Inc., latest Jan 9, 2024 (2 filings since Dec 14, 2022)
  • Lawrence Gold Filed SC 13G/A on SomaLogic, Inc., latest Feb 14, 2023 (2 filings since Feb 11, 2022)
  • Novartis Filed SC 13G on SomaLogic, Inc., latest Oct 8, 2021
  • SomaLogic, Inc. Boulder, Colorado

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What SomaLogic, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$37.5M3 Dec 31, 2022$24.8M3 Dec 31, 2021+51.1%
Accumulated depreciation$17.9M3 Dec 31, 2022$15.2M3 Dec 31, 2021+17.4%
Property and equipment, net$19.6M3 Dec 31, 2022$9.6M3 Dec 31, 2021+104.7%
Operating-lease assets (leased space)$3.9M3 Dec 31, 2022$4.1M3 Jan 1, 2022−4.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$421.8M3 Dec 31, 2022$439.5M3 Dec 31, 2021−4.0%
Marketable securities, current$117.8M3 Dec 31, 2022$218.2M3 Dec 31, 2021−46.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$10.4M3 Dec 31, 2022$03 Dec 31, 2021
Indefinite-lived intangibles (excluding goodwill)$16.7M3 Dec 31, 2022$03 Dec 31, 2021

Inventory

ItemLatestA year beforeChange
Inventory, total$13.9M3 Dec 31, 2022$11.2M3 Dec 31, 2021+23.9%
Raw materials$16.7M3 Dec 31, 2022$15.0M3 Dec 31, 2021+11.2%
Work in process$1.2M3 Dec 31, 2022$175.0K3 Dec 31, 2021+580.6%
Finished goods$639.0K3 Dec 31, 2022$93.0K3 Dec 31, 2021+587.1%

Leadership

Who has led SomaLogic, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Eli Casdin2021
  2. Roy Smythe2021–2022
  3. Adam Taich2023–2024

Chair

  1. Troy Cox2022–2023

President

  1. Melody Harris2021–2022

Chief financial officer

  1. Brian Emes2021
  2. Shaun M. Blakeman2021–2023
  3. Eliot M. Lurier2023

Chief operating officer

  1. Melody Harris2021–2022
2025
Board members and other officers (18)

Former names

  • CM Life Sciences II Inc.Dec 31, 2020 to Sep 1, 20212

Timeline

  1. Jan 5, 20248-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights32
  2. Jan 2, 20248-K Regulation FD disclosure33
  3. Dec 29, 20238-K Regulation FD disclosure34
  4. Dec 29, 20238-K Regulation FD disclosure35
  5. Dec 26, 20238-K Regulation FD disclosure36
  6. Dec 26, 20238-K Regulation FD disclosure37
  7. Dec 21, 20238-K Regulation FD disclosure; Other events38
  8. Dec 12, 20238-K Executive or director change39
  9. Nov 29, 20238-K Regulation FD disclosure40
  10. Nov 21, 20238-K Other events41
  11. Nov 8, 20238-K Results of operations42
  12. Oct 4, 20238-K Entered a material agreement; Executive or director change; Regulation FD disclosure43
  13. Apr 7, 2023New chief executive Adam Taich becomes CEO8
  14. Sep 10, 2021New chief executive Roy Smythe becomes CEO10
  15. Feb 22, 2021New chief executive Eli Casdin becomes CEO9

Calendar

When it reported results

  1. Nov 8, 2023Reported quarterly or annual results42
  2. Aug 14, 2023Reported quarterly or annual results44
  3. May 11, 2023Reported quarterly or annual results45
  4. Mar 28, 2023Reported quarterly or annual results46
  5. Nov 14, 2022Reported quarterly or annual results47
  6. Aug 15, 2022Reported quarterly or annual results48
  7. May 12, 2022Reported quarterly or annual results49
  8. Mar 29, 2022Reported quarterly or annual results50

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

200 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 43 major events, 73 insider forms, 9 large holders, 66 other. The latest 20:

  1. Jan 10, 2025SCHEDULE 13G/A EDGAR
  2. Jan 29, 2024SC 13G/A EDGAR
  3. Jan 29, 2024SC 13G/A EDGAR
  4. Jan 16, 202415-12G EDGAR
  5. Jan 11, 2024EFFECT EDGAR
  6. Jan 11, 2024EFFECT EDGAR
  7. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  8. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  9. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  10. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  11. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  12. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  13. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  14. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  15. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  16. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  17. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  18. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  19. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  20. Jan 9, 2024SC 13D/A EDGAR

The 200 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 0 buys and 6 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 10, 2023Roelke Alison MarieChief People OfficerSale5,675$2.43$13.8KForm 4
Sep 15, 2023Taich AdamInterim CEOSale21,584$2.33$50.3KForm 4
Sep 15, 2023Roelke Alison MarieChief People OfficerSale3,434$2.33$8.0KForm 4
Sep 15, 2023Gutierrez RubenGeneral CounselSale9,211$2.33$21.5KForm 4
Mar 2, 2023Taich AdamInterim CEOSale1,412$2.56$3.6KForm 4
Mar 2, 2023Gutierrez RubenGeneral CounselSale765$2.56$2.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How SomaLogic, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSomaLogic, Inc.1
  • CIK0001837412
  • Employer ID (EIN)85-42989121
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8731 Services-Commercial Physical & Biological Research1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressC/O Somalogic, Inc., 2945 Wilderness Place, Boulder, CO 803011
  • Phone(303) 625-90001
  • Shares outstanding188,071,546 as of Nov 6, 20237
  • Public float$647.8M as of Jun 30, 20223
  • On EDGAR sinceDec 31, 20201
  • Filings299 in all: 4 (73), 8-K (48), 3 (24), 425 (21), DFAN14A (16), CORRESP (11), DEFA14A (11), 424B3 (10)1
    All 45 form types

    10-Q (9), EFFECT (8), POS AM (6), SC 13G (5), UPLOAD (5), S-8 POS (4), SC 13G/A (4), 25-NSE (3), 8-K/A (3), S-4/A (3), S-8 (3), 10-K (2), DEF 14A (2), S-1 (2), S-1/A (2), SC 13D/A (2), SEC STAFF LETTER (2), 15-12G (1), 4/A (1), 424B4 (1), 8-A12B (1), 8-A12B/A (1), ARS (1), AW (1), CERT (1), CT ORDER (1), DEFC14A (1), DEFM14A (1), DRS (1), NT 10-Q (1), POS EX (1), PREC14A (1), S-1MEF (1), S-3 (1), S-4 (1), SC 13D (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Mar 28, 2023
    Quarterly report (10-Q) Nov 8, 2023
    Proxy statement (DEF 14A) Apr 25, 2023
    Latest 8-K (8-K) Jan 5, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    SEC EDGAROther events
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56